Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFSAN 2000 report card

This article was originally published in The Tan Sheet

Executive Summary

Center completes 84 of 108 "A" list activities in first nine months of 2000, Director Joseph Levitt announces Dec. 5. Successes include reducing FOIA request backlog for supplement AERs; all 1998-1999 requests now have been fulfilled. Also, CFSAN and CDER are drawing up a memorandum of understanding outlining the food center's lead enforcement role for structure/function claims. The agency has received 1,400 structure/function notifications since January, sending out 102 "courtesy" letters. A-list priorities not completed include supplement GMPs, which are imminent, and an overall ephedra strategy

You may also be interested in...



CFSAN Congressional Reports On DSHEA, Pearson, Strategic Plan Slated

The Center for Food Safety & Applied Nutrition will submit reports to Congress this fiscal year on the cost of addressing various dietary supplement issues.

CFSAN Congressional Reports On DSHEA, Pearson, Strategic Plan Slated

The Center for Food Safety & Applied Nutrition will submit reports to Congress this fiscal year on the cost of addressing various dietary supplement issues.

CFSAN Congressional Reports On DSHEA, Pearson, Strategic Plan Slated

The Center for Food Safety & Applied Nutrition will submit reports to Congress this fiscal year on the cost of addressing various dietary supplement issues.

Related Content

Topics

UsernamePublicRestriction

Register

PS091979

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel